Article
Development and Optimization of Oligonucleotide Ligation Assay (OLA) Probes for Detection of HIV-1 Resistance to Dolutegravir.
Viruses - 19 Jul 2024
Beck Ingrid A, Boyce Ceejay L, Bishop Marley D, Vu Yen L, Fung Amanda, Styrchak Sheila, Panpradist Nuttada, Lutz Barry R, Frenkel Lisa M
Abstract excerpt
The WHO currently recommends dolutegravir (DTG)-based ART for persons living with HIV infection in resource-limited-settings (RLS). To expand access to testing for HIV drug resistance (DR) to DTG in RLS, we developed probes for use in the oligonucleotide ligation assay (OLA)-Simple, a near-point of care HIV DR kit. Genotypic data from clinical trials and case reports were used to determine the mutations in HIV-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
